These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7524758)

  • 1. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells.
    Nichols GL; Raines MA; Vera JC; Lacomis L; Tempst P; Golde DW
    Blood; 1994 Nov; 84(9):2912-8. PubMed ID: 7524758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.
    Salgia R; Uemura N; Okuda K; Li JL; Pisick E; Sattler M; de Jong R; Druker B; Heisterkamp N; Chen LB
    J Biol Chem; 1995 Dec; 270(49):29145-50. PubMed ID: 7493940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
    J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphorylation of murine Crkl.
    de Jong R; Haataja L; Voncken JW; Heisterkamp N; Groffen J
    Oncogene; 1995 Oct; 11(8):1469-74. PubMed ID: 7478571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin.
    Oda A; Miyakawa Y; Druker BJ; Ishida A; Ozaki K; Ohashi H; Wakui M; Handa M; Watanabe K; Okamoto S; Ikeda Y
    Blood; 1996 Dec; 88(11):4304-13. PubMed ID: 8943867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia.
    Oda T; Heaney C; Hagopian JR; Okuda K; Griffin JD; Druker BJ
    J Biol Chem; 1994 Sep; 269(37):22925-8. PubMed ID: 8083188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    J Biol Chem; 1995 Sep; 270(37):21468-71. PubMed ID: 7545163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia.
    ten Hoeve J; Arlinghaus RB; Guo JQ; Heisterkamp N; Groffen J
    Blood; 1994 Sep; 84(6):1731-6. PubMed ID: 7521685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR-ABL oncoprotein is expressed by platelets from CML patients and associated with a special pattern of CrkL phosphorylation.
    ten Bosch GJ; Kessler JH; Blom J; Joosten AM; Gambacorti-Passerini C; Melief CJ; Leeksma OC
    Br J Haematol; 1998 Dec; 103(4):1109-15. PubMed ID: 9886328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
    Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.
    Frietsch JJ; Kastner C; Grunewald TG; Schweigel H; Nollau P; Ziermann J; Clement JH; La Rosée P; Hochhaus A; Butt E
    Oncotarget; 2014 Jul; 5(14):5257-71. PubMed ID: 24913448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells.
    Grumbach IM; Mayer IA; Uddin S; Lekmine F; Majchrzak B; Yamauchi H; Fujita S; Druker B; Fish EN; Platanias LC
    Br J Haematol; 2001 Feb; 112(2):327-36. PubMed ID: 11167825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
    Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
    Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRKL binding to BCR-ABL and BCR-ABL transformation.
    Kolibaba KS; Bhat A; Heaney C; Oda T; Druker BJ
    Leuk Lymphoma; 1999 Mar; 33(1-2):119-26. PubMed ID: 10194128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    Oncogene; 1997 Feb; 14(5):507-13. PubMed ID: 9053848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl.
    de Jong R; van Wijk A; Haataja L; Heisterkamp N; Groffen J
    J Biol Chem; 1997 Dec; 272(51):32649-55. PubMed ID: 9405482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients.
    Kardinal C; Konkol B; Schulz A; Posern G; Lin H; Adermann K; Eulitz M; Estrov Z; Talpaz M; Arlinghaus RB; Feller SM
    FASEB J; 2000 Aug; 14(11):1529-38. PubMed ID: 10928987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.
    Bhat A; Kolibaba K; Oda T; Ohno-Jones S; Heaney C; Druker BJ
    J Biol Chem; 1997 Jun; 272(26):16170-5. PubMed ID: 9195915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia.
    Wisniewski D; Strife A; Berman E; Clarkson B
    Leukemia; 1996 Feb; 10(2):229-37. PubMed ID: 8637231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.